Q/C Technologies, Inc. Litigation Settlement, Expense
Q/C Technologies, Inc. (QCLS) reported Litigation Settlement, Expense of $40.00 thousand for the 3-month period ending 2022-09-30, per its 10-Q filed 2022-11-10.
Discontinued › Expense Statement › Operating Expenses
us-gaap:LitigationSettlementExpense · last filed 2022-11-10
- Q/C Technologies, Inc. litigation settlement, expense for the quarter ending 2022-09-30 was $40.00K, a 33.33% decline year-over-year.
- Q/C Technologies, Inc. litigation settlement, expense for the quarter ending 2022-06-30 was $50.00K, a 19.05% increase year-over-year.
- Q/C Technologies, Inc. litigation settlement, expense for the quarter ending 2021-09-30 was $60.00K.
- Q/C Technologies, Inc. litigation settlement, expense for the quarter ending 2021-06-30 was $42.00K, a 48.60% decline year-over-year.
- Q/C Technologies, Inc. litigation settlement, expense for fiscal 2019 was $75.00K, a 95.02% decline from fiscal 2018.
- Q/C Technologies, Inc. litigation settlement, expense for fiscal 2018 was $1.50M.
| Period end | Litigation Settlement, Expense 0 month | Litigation Settlement, Expense 3 month | Litigation Settlement, Expense 6 month | Litigation Settlement, Expense 9 month | Litigation Settlement, Expense 12 month | Litigation Settlement, Expense 12 month as first filed |
|---|---|---|---|---|---|---|
| 2022-09-30 | $40.00K 10-Q · filed 2022-11-10 | $90.00K derived: sum of 2 quarters · filed 2022-11-10 | $138.00K 10-Q · filed 2022-11-10 | |||
| 2022-06-30 | $50.00K 10-Q · filed 2022-08-15 | $98.00K 10-Q · filed 2022-08-15 | ||||
| 2021-09-30 | $60.00K 10-Q · filed 2022-11-10 | $102.00K derived: sum of 2 quarters · filed 2022-11-10 | $126.00K 10-Q · filed 2022-11-10 | |||
| 2021-06-30 | $42.00K 10-Q · filed 2022-08-15 | $71.00K 10-Q · filed 2022-08-15 | ||||
| 2020-06-30 | $81.72K 10-Q · filed 2020-08-14 | $81.72K 10-Q · filed 2020-08-14 | ||||
| 2019-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-01 | $0.00 derived: sum of 2 quarters · filed 2021-03-01 | $0.00 derived: sum of 3 quarters · filed 2021-03-01 | $75.00K 10-K · filed 2021-03-01 | $141.48K 10-K · filed 2020-03-25 | |
| 2019-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-16 | $0.00 derived: sum of 2 quarters · filed 2020-11-16 | $75.00K 10-Q · filed 2020-11-16 | $650.00K derived: sum of 4 quarters · filed 2020-11-16 | ||
| 2019-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-14 | $75.00K 10-Q · filed 2020-08-14 | $650.00K derived: sum of 3 quarters · filed 2020-08-14 | $1.58M derived: sum of 4 quarters · filed 2020-08-14 | ||
| 2019-03-31 | $75.00K 10-Q · filed 2020-05-15 | $650.00K derived: sum of 2 quarters · filed 2020-05-15 | $1.58M derived: sum of 3 quarters · filed 2020-05-15 | |||
| 2018-12-31 | $575.00K derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-25 | $1.50M derived: sum of 2 quarters · filed 2020-03-25 | $1.50M 10-K · filed 2020-03-25 | |||
| 2018-10-09 | $930.00K 10-K · filed 2019-04-01 | |||||
| 2018-09-30 | $930.00K 10-Q · filed 2019-11-14 | $930.00K 10-Q · filed 2019-11-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Cardio Diagnostics Holdings, Inc. (CDIO) | United States | $0.006B | |
| BIOMERICA INC (BMRA) | United States | $0.011B | |
| VOLITIONRX LTD (VNRX) | $0.003B | -0.64 | |
| IMMUCELL CORP /DE/ (ICCC) | United States | $0.091B | 116.10 |
| Insight Molecular Diagnostics Inc. (IMDX) | United States | $0.129B | -3.90 |
| MYRIAD GENETICS INC (MYGN) | United States | $0.397B | -4.84 |
| Alpha Teknova, Inc. (TKNO) | United States | $0.500B | -18.12 |
| QuidelOrtho Corp (QDEL) | United States | $0.733B | -0.90 |
| ACHIEVE LIFE SCIENCES, INC. (ACHV) | United States | $0.806B | -5.88 |
| Intellia Therapeutics, Inc. (NTLA) | United States | $1.705B | -5.92 |